HOB Biotech Group Corp Ltd (688656) — Capital Reinvestment Ratio
HOB Biotech Group Corp Ltd (688656) has a Capital Reinvestment Ratio of 0.56x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥15.28 Million) in capital expenditures (CN¥8.50 Million). Check tangible net worth ratio of HOB Biotech Group Corp Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
HOB Biotech Group Corp Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks HOB Biotech Group Corp Ltd's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see HOB Biotech Group Corp Ltd cash flow conversion.
Annual Capital Reinvestment Ratio for HOB Biotech Group Corp Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for HOB Biotech Group Corp Ltd from 2016 to 2025. See how much free cash does HOB Biotech Group Corp Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.01x | CN¥72.94 Million | CN¥73.90 Million | ▼ -34.0% |
| 2024 | 1.53x | CN¥101.22 Million | CN¥155.37 Million | ▼ -11.5% |
| 2023 | 1.73x | CN¥102.69 Million | CN¥178.03 Million | ▼ -54.1% |
| 2022 | 3.78x | CN¥58.31 Million | CN¥220.21 Million | ▲ +135.7% |
| 2021 | 1.60x | CN¥104.79 Million | CN¥167.89 Million | ▲ +63.6% |
| 2020 | 0.98x | CN¥58.22 Million | CN¥57.01 Million | ▲ +93.0% |
| 2019 | 0.51x | CN¥68.57 Million | CN¥34.80 Million | ▼ -11.5% |
| 2018 | 0.57x | CN¥46.51 Million | CN¥26.66 Million | ▼ -38.7% |
| 2017 | 0.94x | CN¥22.26 Million | CN¥20.82 Million | ▼ -65.0% |
| 2016 | 2.67x | CN¥6.42 Million | CN¥17.15 Million | — |